This work is licensed under a Creative Commons Attribution 4.0 International License.
Peptide P
General Information
DRACP ID DRACP00431
Peptide Name Peptide P
Sequence KWKSFLKTFKSLKKTVLHTLLKAISS
Sequence Length 26
UniProt ID Not available
PubChem CID Not available
Origin Acetylation
Type Synthetic peptide
Classification
Active ACP
Activity Information
| Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
|---|---|---|---|---|---|---|
| HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=1.71±0.07 µmol/L | MTS assay | 1 h | 1 |
Hemolytic Activity Human red blood cells: MHC=5.20±0.02 μmol/L
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Acetylation
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C145H242N36O34
Absent amino acids CDEGMNPQRY
Common amino acids K
Mass 347983
Pl 11.58
Basic residues 8
Acidic residues 0
Hydrophobic residues 11
Net charge 8
Boman Index -2116
Hydrophobicity -6.15
Aliphatic Index 105
Half Life
Mammalian: 1.3 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 5500
Absorbance 280nm 220
Polar residues 7
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 22837667
Title Role of helicity on the anticancer mechanism of action of cationic-helical peptides
Year 2012
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
This work is licensed under a Creative Commons Attribution 4.0 International License.